%0 Journal Article
%T Bevacizumab for Glioblastoma¡ªA Promising Drug or Not?
%A Motoo Nagane
%A Ryo Nishikawa
%J Cancers
%D 2013
%I MDPI AG
%R 10.3390/cancers5041456
%X Two double blind, placebo-controlled, and randomized phase III studies were conducted, and the results including OS¡¯s were reported at the ASCO Meeting in June 2013, which was the beginning of confusion surrounding this topic. This is a review article not only summarizing the previous evidence, but also looking beyond.
%K bevacizumab
%K glioblastoma
%K chemotherapy
%U http://www.mdpi.com/2072-6694/5/4/1456